Pharmaceutical

Zai Lab and Pfizer to commercialise XACDURO in China

Zai Lab and Pfizer have entered a strategic collaboration for the commercialisation of XACDURO in mainland China.

Nov 23, 2024 - 06:00
Zai Lab and Pfizer to commercialise XACDURO in China
Zai Lab and Pfizer have entered a strategic collaboration for the commercialisation of XACDURO in mainland China.
Read the original article

Tags:

Previous Article

Amneal files again for FDA approval of first dihydroergotamine autoinjector

Next Article

Magazine: Pharma’s green shift with dry powder inhalers

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Gavi to obtain 500,000 mpox vaccine doses from Bavarian Nordic

Gavi to obtain 500,000 mpox vaccine doses from Bavarian...

Sep 20, 2024

Sun Pharmaceutical Industries sees highest patent filin...

Dec 10, 2023

Cullinan advances multiple myeloma drug CLN-619 to a Phase I study

Cullinan advances multiple myeloma drug CLN-619 to a Ph...

Mar 1, 2024